Skip to main content
. 2024 Nov 15;15:1408224. doi: 10.3389/fneur.2024.1408224

Figure 2.

Figure 2

Experimental design summary. (1) From 5/2019 to 12/2021, individuals of varying diagnostic status were seen. (2) Patients underwent a full neurological examination, yielding NeurEx and disability scale scores. (3) Patients also received brain and spinal cord MRI which were rated semi-quantitatively. (4) Patients completed digital tests, including the short walk and foot tapping tests. (5) Finally, patients completed a timed 25-foot walk. (6) and (7) MS patients were assigned to either a training cohort or validation cohort. (8) Digital biomarkers were extracted from the short walk and foot tapping tests. (9) Only biomarkers with test-retest reliability were kept. (10) These reliable biomarkers were correlated against clinical and imaging outcomes. (11) and (12) These features were next used to build elastic net models of relevant clinical outcomes. (13) Finally, the performance of these models was evaluated in the independent validation cohort.